STIGALL L. JEREMY (GM, Biologics & Drug Delivery) exercised options at CLEARPOINT NEURO, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/13/2026ACC: 0001193125-26-105953
Officer· GM, Biologics & Drug Delivery
Since May 2022
-3.22K
Net shares
Net seller
$37.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
8.29K acquired · 11.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.29K
Price / share
—
Trade value
—
% of position
9.5%
3/11/2026
87.57K→95.86K
Common Stock
Direct
Shares
−3.22K
Price / share
$11.62
Trade value
$37.46K
% of position
3.4%
3/11/2026
95.86K→92.64K
Total
Net shares
+5.07K
Net value
-$37.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | M · Option Exercise | +8.29K | — | — | 9.5% | 87.57K | 95.86K |
| Common Stock Direct | 3/11/2026 | F · Tax Withholding | −3.22K | $11.62 | $37.46K | 3.4% | 95.86K | 92.64K |
| Total | +5.07K | -$37.46K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
8.29K shares
Shares
−8.29K
Strike price
Held after
0.00
Exercisable
—
3/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock8.29K shares | 3/11/2026 | M · Option Exercise | −8.29K | — | 0.00 |